1.Clinical and laboratory findings of rhabdomyolysis in opioid overdose patients in the intensive care unit of a poisoning center in 2014 in Iran.
Khoshideh BABAK ; Arefi MOHAMMAD ; Ghorbani MAZAHER ; Akbarpour SAMANEH ; Taghizadeh FATEMEH
Epidemiology and Health 2017;39(1):e2017050-
OBJECTIVES: The aim of this study was to investigate the clinical and demographic characteristics and some laboratory findings of hospitalized patients with acute opioid toxicity and rhabdomyolysis. METHODS: This cross-sectional study investigated 354 patients hospitalized at Baharloo Hospital in Tehran in 2014 with acute illicit drug toxicity. Data were collected using an investigator-made checklist. The collected data (such as mortality rate, demographic data, and renal function tests, as well as serum biochemical findings) were analyzed by descriptive statistics and the chi-square test. RESULTS: A total of 354 patients were admitted to the hospital in 2014 with acute illicit drug toxicity, including 291 males and 63 females. The total number of patients with rhabdomyolysis was 76 (21.5% of the total), of whom 69 (90.8%) were male and 7 (9.2%) were female. Most cases of rhabdomyolysis were associated with methadone abuse, followed by opium abuse. Rhabdomyolysis was most common in those 20–29 and 30–39 years old, with methadone and opium the most commonly abused illicit drugs. The mean blood urea level was 3.8±1.0 mg/dL, and the mean serum potassium and sodium levels were 3.8±0.3 mg/dL and 140.4±4.0 mg/dL, respectively. Five patients, all of whom were male, passed away due to severe renal failure (6.5%). CONCLUSIONS: Toxicity caused by opioids is associated with clinical complications and laboratory disorders, such as electrolyte disorders, which can lead to lethal or life-threatening results in some cases. Abnormal laboratory test findings should be identified in patients with opioid toxicity in order to initiate efficient treatment.
Analgesics, Opioid
;
Checklist
;
Critical Care*
;
Cross-Sectional Studies
;
Drug-Related Side Effects and Adverse Reactions
;
Female
;
Humans
;
Intensive Care Units*
;
Iran*
;
Male
;
Methadone
;
Mortality
;
Opium
;
Poisoning*
;
Potassium
;
Renal Insufficiency
;
Rhabdomyolysis*
;
Sodium
;
Street Drugs
;
Urea
2.Clinical and laboratory findings of rhabdomyolysis in opioid overdose patients in the intensive care unit of a poisoning center in 2014 in Iran
Khoshideh BABAK ; Arefi MOHAMMAD ; Ghorbani MAZAHER ; Akbarpour SAMANEH ; Taghizadeh FATEMEH
Epidemiology and Health 2017;39(1):2017050-
OBJECTIVES: The aim of this study was to investigate the clinical and demographic characteristics and some laboratory findings of hospitalized patients with acute opioid toxicity and rhabdomyolysis.METHODS: This cross-sectional study investigated 354 patients hospitalized at Baharloo Hospital in Tehran in 2014 with acute illicit drug toxicity. Data were collected using an investigator-made checklist. The collected data (such as mortality rate, demographic data, and renal function tests, as well as serum biochemical findings) were analyzed by descriptive statistics and the chi-square test.RESULTS: A total of 354 patients were admitted to the hospital in 2014 with acute illicit drug toxicity, including 291 males and 63 females. The total number of patients with rhabdomyolysis was 76 (21.5% of the total), of whom 69 (90.8%) were male and 7 (9.2%) were female. Most cases of rhabdomyolysis were associated with methadone abuse, followed by opium abuse. Rhabdomyolysis was most common in those 20–29 and 30–39 years old, with methadone and opium the most commonly abused illicit drugs. The mean blood urea level was 3.8±1.0 mg/dL, and the mean serum potassium and sodium levels were 3.8±0.3 mg/dL and 140.4±4.0 mg/dL, respectively. Five patients, all of whom were male, passed away due to severe renal failure (6.5%).CONCLUSIONS: Toxicity caused by opioids is associated with clinical complications and laboratory disorders, such as electrolyte disorders, which can lead to lethal or life-threatening results in some cases. Abnormal laboratory test findings should be identified in patients with opioid toxicity in order to initiate efficient treatment.
Analgesics, Opioid
;
Checklist
;
Critical Care
;
Cross-Sectional Studies
;
Drug-Related Side Effects and Adverse Reactions
;
Female
;
Humans
;
Intensive Care Units
;
Iran
;
Male
;
Methadone
;
Mortality
;
Opium
;
Poisoning
;
Potassium
;
Renal Insufficiency
;
Rhabdomyolysis
;
Sodium
;
Street Drugs
;
Urea
3.Montanide ISA-720 and Naloxone in HBsAg Vaccine Formulation: Cytokine Profiling and Monitoring of Long-Lasting Humoral Immune Responses.
Mina MIRZAEE ; Setareh HAGHIGHAT ; Bahareh GOLKARAN ; Fatemeh ASGARHALVAEI ; Rayhaneh MIRZAEE ; Morteza TAGHIZADEH ; Mohammad Ali SAVOJI ; Behzad ESFANDIARI ; Mehdi MAHDAVI
Biomedical and Environmental Sciences 2022;35(9):792-803
OBJECTIVE:
This study aimed to investigate the effects of Montanide ISA-720 and Naloxone (NLX) in Hepatitis B surface antigen (HBsAg) vaccine formulation on cytokine and long-lasting antibody responses.
METHODS:
First, the HBsAg was formulated in Montanide ISA-720 adjuvant and Naloxone at 5 and 10 mg/kg. The experimental mice were immunized three times at a 2-week interval, and then IL-4, IL-2, TNF-α, and IFN-γ cytokines; long-lasting IgG antibody responses 220 days after the last shot; and IgG1/IgG2a isotypes were assessed by ELISA.
RESULTS:
The HBsAg-Alum group exhibited the highest IL-4 cytokine response among the experimental groups, whereas NLX in HBsAg-MON720 vaccine formulation did not affect cytokine responses. In addition, NLX in Alum-based vaccine suppressed IL-4 cytokine response and increased the IL-2/IL-4 cytokine ratio. Moreover, HBsAg-MON720 was more potent than HBsAg-Alum in the induction of antibody responses, and NLX in Alum- and MON720-based vaccines induced long-lasting antibody responses.
CONCLUSION
NLX in Alum-based vaccine decreased IL-4 cytokine response, increased IL-2/IL-4 cytokine ratio, and improved long-lasting humoral immune responses in both vaccine formulations. Therefore, the adjuvant activity of NLX in the vaccine formulation depends on the type of adjuvant and the nature of the antigen in the vaccine formulation.
Adjuvants, Immunologic/pharmacology*
;
Alum Compounds
;
Animals
;
Cytokines
;
Hepatitis B Surface Antigens
;
Hepatitis B Vaccines
;
Immunity, Humoral
;
Immunoglobulin G
;
Interleukin-2
;
Interleukin-4
;
Mice
;
Mice, Inbred BALB C
;
Mineral Oil
;
Naloxone/pharmacology*
;
Tumor Necrosis Factor-alpha